title: Therapeutic options or antiretroviral anarchy?
authors.forename: M
authors.initials: M
authors.lastname: Mascolini
mesh_terms: D019380:Anti-HIV Agents / Q000627:therapeutic use*; D018791:CD4 Lymphocyte Count; D002986:Clinical Trials as Topic; D003226:Congresses as Topic; D018450:Disease Progression; D004352:Drug Resistance, Microbial; D004359:Drug Therapy, Combination; D015507:Drugs, Investigational; D015658:HIV Infections / Q000188:drug therapy* / Q000276:immunology; D015497:HIV-1 / Q000187:drug effects*; D006801:Humans; D011788:Quality of Life; D012367:RNA, Viral / Q000097:blood; D012606:Scotland; D013997:Time Factors; D019562:Viral Load; D014779:Virus Replication / Q000187:drug effects
chemical_list: D019380:Anti-HIV Agents; D015507:Drugs, Investigational; D012367:RNA, Viral